Format

Send to

Choose Destination
N Engl J Med. 2011 Mar 10;364(10):947-55. doi: 10.1056/NEJMct0807960.

Treatment of non-small-cell lung cancer with erlotinib or gefitinib.

Author information

1
Louisiana State University Health Sciences Center and Hematology-Oncology Clinic, Baton Rouge, LA 70805, USA. vincelsu@aol.com

Abstract

A 64-year-old woman receives the diagnosis of metastatic non-small-cell lung cancer (NSCLC), which has progressed during treatment with carboplatin, paclitaxel, and bevacizumab. Erlotinib therapy is recommended.

PMID:
21388312
DOI:
10.1056/NEJMct0807960
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center